SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,895.74 315.20
( 0.43%)

Global Indices

Nasdaq

51,370.81 -161.78
(-0.31%)

Dow Jones

7,725.73 -1.30
(-0.02%)

Hang Seng

66,308.10 794.11
(1.21%)

Nikkei 225

10,680.49 -24.77
(-0.23%)

Forex

USD-INR

95.73 0.08
(0.09%)

EUR-INR

109.20 -0.36
(-0.33%)

GBP-INR

127.12 -0.62
(-0.48%)

JPY-INR

0.61 0.00
(-0.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Oxygenta Pharmaceutical Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524636

INE102E01018

-11.5421201

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

187.91

EPS(TTM)

Face Value()

Div & Yield %

Back

3B Blackbio DX consolidated net profit declines 24.31% in the June 2026 quarter

Aug 13,2026

Net profit of 3B Blackbio DX declined 24.31% to Rs 9.53 crore in the quarter ended June 2026 as against Rs 12.59 crore during the previous quarter ended June 2025. Sales rose 50.65% to Rs 33.49 crore in the quarter ended June 2026 as against Rs 22.23 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	33.49	22.23	51
OPM %	25.47	53.22	-
PBDT	14.56	16.14	-10
PBT	13.22	15.86	-17
NP	9.53	12.59	-24

73,895.74 315.20 ( 0.43%)

51,370.81 -161.78 (-0.31%)

7,725.73 -1.30 (-0.02%)

66,308.10 794.11 (1.21%)

10,680.49 -24.77 (-0.23%)

95.73 0.08 (0.09%)

109.20 -0.36 (-0.33%)

127.12 -0.62 (-0.48%)

0.61 0.00 (-0.28%)